(Press-News.org) Max Planck Digital Library and BioOne announced the signing of a three-year agreement to bring the flagship BioOne Complete aggregation to 84 Max Planck Society Institutes. Notably, this agreement includes the full term of BioOne’s Subscribe to Open (S2O) pilot from 2026 through 2028, supporting shared goals of sustainable open access and equitable scholarly communications.
BioOne’s Subscribe to Open pilot brings together 71 journals from 54 societies, museums, and research organizations worldwide into a conditional open access framework —representing the largest number of independent publishers under a single S2O offer to date. This agreement ensures that all 84 Max Planck Institutes maintain reading access to the full BioOne Complete’s collection of over 230,000 biological sciences articles while simultaneously advancing open access objectives. Success of this pilot will also connect Max Planck Institute-affiliated researchers with broader audiences throughout the international biosciences community.
“We appreciate Max Planck Society’s commitment to BioOne’s community of nonprofit publishers,” said Christine Orr, BioOne’s Senior Director of Business and Community Development. “As long-term library partners spanning more than two decades, the Max Planck Society has consistently supported BioOne’s mission. This agreement underscores the Max Planck’s sustained dedication to sustainable scholarly communications and to broadening the reach of critical research from the scientific communities we serve.”
Ádám Dér, Head of the Scientific Information Provision at the Max Planck Digital Library remarked: “We’re pleased to support BioOne’s Subscribe to Open pilot, through which we not only serve our researchers but also contribute to the wider scholarly community. This agreement reflects our long-standing goal of making research accessible to all and our commitment to supporting diverse pathways toward open scholarship, ensuring our researchers can both access and share knowledge freely while supporting independent scholarly publishers.”
Throughout the S2O pilot, BioOne Complete will be a mixed model collection of 219 subscribed, S2O, and OA titles. With sufficient support from subscribing libraries, current-year content of the 71 S2O titles will be made open access. If the sustainability threshold is not met, that content will remain available only to subscribers. Supporting subscribers exclusively benefit from access to all current and backfile content from both S2O and gated titles.
BioOne and Max Planck Digital Library are proud to advance our shared vision of creating a more open future while ensuring the sustainability of both nonprofit publishers and libraries.
Learn more about BioOne’s Subscribe to Open pilot.
About BioOne
BioOne is an innovative nonprofit collaborative and the leading content aggregator in the biological, ecological, and environmental sciences. More than 150 global scientific societies and nonprofit publishing organizations include their journals in BioOne’s flagship product, BioOne Complete, for the benefit of 3,500 accessing institutions and millions of researchers worldwide. Since 2001, BioOne has returned more than 78 million USD in royalty sharing back to its participants, with a commitment to share research more broadly, equitably, and sustainably.
About the Max Planck Digital Library
The Max Planck Digital Library is a central unit of the Max Planck Society for the Advancement of Science (MPG) and supports all researchers of the MPG with expert digital services. One of Europe’s largest research libraries, the MPDL provides easy access to scientific literature, data, commercial software licenses, scientific communication tools and services, and research-relevant software applications. The MPDL has a transformative impact on commercial product development and the scientific publishing market for the benefit of the MPG and science overall. Learn more about the Max Planck Digital Library.
END
BioOne and Max Planck Society sign 3-year agreement to include subscribe to open pilot
Three-year agreement will deliver access to 84 Max Planck Institutes and support sustainable open access for independent nonprofit publishers.
2025-10-31
ELSE PRESS RELEASES FROM THIS DATE:
How the arts and science can jointly protect nature
2025-10-31
A new study by a large international team of conservation scientists and artists explores how growing synergies between conservation and the arts can unveil many mutual benefits and fresh approaches to intractable conservation problems. “These collaborations can generate new knowledge, attract funding, boost visibility, and even catalyze behavioural change”, says Ivan Jarić, researcher from the University of Paris-Saclay in France and the Czech Academy of Sciences, and lead author of the study. “By working ...
Student's unexpected rise as a researcher leads to critical new insights into HPV
2025-10-31
When Sean Fletcher walked into Sam Biswas’ Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of Health Sciences during the summer of his first year, he had no research or laboratory experience.
Two years later, the senior honors medical diagnostics major has published a paper as a first author after uncovering new insights into how human papillomavirus (HPV) functions on a molecular level.
In a study recently published in Virology Journal, Fletcher and co-authors Biswas, professor of MMSC, and Esther Biswas-Fiss, professor and chair of MMSC, used bioinformatics to pinpoint conserved ...
Ominous false alarm in the kidney
2025-10-31
Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering a chain reaction. In cooperation with Nanyang Technological University Singapore and the University Hospital Würzburg, among others, the study provides an explanation for how a point mutation in the immune receptor RIG-I transforms the body's defense system into a self-destructive force and causes severe organ-specific autoimmune diseases. The results have now been published in the journal Science Immunology.
RIG-I is an important ...
MSK Research Highlights, October 31, 2025
2025-10-31
New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers unique genetic signatures in cancer patients of non-European ancestry; identifies social adversity as a potential risk factor for higher rates of triple-negative breast cancer among Black women; shows a web-based system could help head-and-neck cancer survivors report their concerns; and finds adding immunotherapy can boost the effectiveness for hard-to-treat follicular lymphomas.
Study uncovers unique genetic signatures in cancer patients of non-European ancestry
In the era of personalized oncology, it’s becoming increasingly important to ...
Lisbon to host world’s largest conference on ecosystem restoration in 2027, led by researcher from the Faculty of Sciences, University of Lisbon
2025-10-31
The announcement was made in early October in Denver, USA, during the 11th edition of the conference, and marks the first time Portugal will host this prestigious international event. The proposal, coordinated by Dr. Nunes, was selected by an international panel of experts and received enthusiastic support from global institutions, including several regional chapters of the Society for Ecological Restoration (SER).
“Ecosystem restoration lies at the heart of tackling the climate and biodiversity crises, ...
Electrocatalysis with dual functionality – an overview
2025-10-31
Hybrid electrocatalysts can produce green hydrogen, for example, and valuable organic compounds simultaneously. This promises economically viable applications. However, the complex catalytic reactions involved in producing organic compounds are not yet fully understood. Modern X-ray methods at synchrotron sources such as BESSY II, enable catalyst materials and the reactions occurring on their surfaces to be analysed in real time, in situ and under real operating conditions. This provides insights ...
Scripps Research awarded $6.9 million by NIH to crack the code of lasting HIV vaccine protection
2025-10-31
LA JOLLA, CA—Nearly 40 years after HIV was first identified, the virus continues its devastating march across the globe. Today, 38 million people live with HIV, and each year brings 1.5 million new infections and 650,000 more deaths—while nearly 10 million people still lack access to life-saving medicines. Despite decades of intensive research and remarkable progress in treatment, one goal remains frustratingly out of reach: a vaccine that provides lasting protection.
Now, a team of scientists at Scripps Research has been awarded a $6.9 million five-year grant from the National Institutes of Health (NIH) to address this specific challenge. Led by Bryan Briney, associate ...
New post-hoc analysis shows patients whose clinicians had access to GeneSight results for depression treatment are more likely to feel better sooner
2025-10-31
SALT LAKE CITY, Oct. 30, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that treatment informed by the GeneSight® test led to faster initial remission and response in patients with Major Depressive Disorder (MDD). Further, the post-hoc analysis showed that this benefit persisted over six months with no evidence of changing over time.
“Every single day matters to someone suffering from depression; patients want to get back to feeling like themselves as quickly ...
First transplant in pigs of modified porcine kidneys with human renal organoids
2025-10-31
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research Institute of A Coruña (INIBIC), as well as other international research groups, has developed pioneering technology that enables human kidney organoids to be produced in a scalable manner. This technology allows the organoids to be combined with pig kidneys outside the body and then transplanted back into the same animal to evaluate their viability. This breakthrough study, published in the journal Nature Biomedical ...
Reinforcement learning and blockchain: new strategies to secure the Internet of Medical Things
2025-10-31
Critical concerns regarding the security and privacy of information transmitted within Internet of Medical Things systems have increased greatly, since these systems manage and generate substantial amounts of sensitive private data. Current traditional security methods have not yet adapted to evolving cyber threats, making the need for data security in medical settings crucial. Recently, a security framework based on blockchain technology and distributed reinforcement learning has been developed to address these challenges. The new framework ...
LAST 30 PRESS RELEASES:
Study reports on global trends in acute kidney injury– related mortality
Study reveals a potentially better way to optimize the timing for kidney transplant waitlisting
Transitional dialysis program in Texas decreased the use of emergency dialysis
Quality improvement intervention may help prevent deaths from metformin-associated lactic acid
Conservative care versus dialysis: model indicates which is best for individual patients with advanced chronic kidney disease
Coronary artery calcium may be a predictor for all-cause mortality, including medical conditions not related to heart health
Minimally invasive coronary calcium CT scans used to determine heart disease risk are effective at finding other potential health problems
High-impact clinical trials generate promising results for improving kidney health - part 3
Mass General Brigham researchers find PCSK9 inhibitor reduced risk of first heart attack, stroke
Triglyceride-lowering drug significantly reduced rate of acute pancreatitis in high-risk patients
Steatotic liver disease and cancer: From pathogenesis to therapeutic frontiers
SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria
Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function
Temporary benefit for immune system in early HIV treatment, but dysregulation returns
Chronic kidney disease is now the ninth leading cause of death
Chronic kidney disease has more than doubled since 1990, now affecting nearly 800 million people worldwide
Participant experiences in a kidney failure care intervention in the navigate-kidney study
Community health worker support for Hispanic and Latino individuals receiving hemodialysis
Scientists unveil new strategies to balance farming and ecological protection in Northeast China
UT Health San Antonio scientist helps shape new traumatic brain injury guidelines
Rising nitrogen and rainfall could supercharge greenhouse gas emissions from the world’s largest grasslands
Study uncovers glomerular disease outcomes across the lifespan
Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats
Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering
A husband’s self-esteem may protect against preterm births, study finds
Michigan State University's James Madison College receives over $1 million to launch civic education academy
White paper on recovering from burnout through mentoring released by University of Phoenix College of Doctoral Studies
Defunct Pennsylvania oil and gas wells may leak methane, metals into water
Kessler Foundation’s John DeLuca, PhD, honored with Reitan Clinical Excellence Award from National Academy of Neuropsychology
Discordance in creatinine- and cystatin C–based eGFR and clinical outcomes
[Press-News.org] BioOne and Max Planck Society sign 3-year agreement to include subscribe to open pilotThree-year agreement will deliver access to 84 Max Planck Institutes and support sustainable open access for independent nonprofit publishers.